Safety and efficacy of BIC/FIC/TAF in older PLHIV: impact on bone density, renal function, and lipid profiles in a real-world Chinese cohort
Chengyu Gao, Yi Ding, Jialu Li, Yining Zhao, Qinlan Li, Ying Liu, Hongyuan Liang, Liang Ni, Fang Wang, Sa Wang, Di Yang, Guiju Gao, Jiang Xiao, Hongxin Zhao · 2025
Read Safety and efficacy of BIC/FIC/TAF in older PLHIV: impact on bone density, renal function, and lipid profiles in a real-world Chinese cohort by Chengyu Gao, Yi Ding, Jialu Li, Yining Zhao, Qinlan Li, Ying Liu, Hongyuan Liang, Liang Ni, Fang Wang, Sa Wang, Di Yang, Guiju Gao, Jiang Xiao, Hongxin Zhao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729750.txt.
Description
Chengyu Gao and thirteen co-authors assess a fixed-dose HIV drug combination in older Chinese patients in real-world care, in a study from 2025. Older patients face bone, kidney, and lipid concerns that shape drug choice. Clinic data can show how the regimen performs outside trials.
They followed 314 patients over fifty, both new and experienced users, for forty-eight weeks. The regimen controlled virus well, even in a few patients with a key resistance mutation. Bone density at the spine fell modestly, while hip density and kidney markers tended to improve. Kidney filtration estimates dipped and one blood fat rose, which needs monitoring.
Catalog record
| CREATOR | Chengyu Gao, Yi Ding, Jialu Li, Yining Zhao, Qinlan Li, Ying Liu, Hongyuan Liang, Liang Ni, Fang Wang, Sa Wang, Di Yang, Guiju Gao, Jiang Xiao, Hongxin Zhao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |